DEPARTMENT OF PHARMACEUTICALS
MINISTRY OF CHEMICALS AND
FERTILIZERS, GOVERNMENT OF INDIA
INDIAN DRUG MANUFACTURERS’
ASSOCIATION
(IDMA)
JOINTLY PRESENTS
SEMINAR ON “IMPLICATIONS OF GST (GOODS &
SERVICE TAX) ON PHARMA INDUSTRY”
MONDAY, 21ST DECEMBER 2015 FROM 9:30 A.M. TO 5:00 P.M.
HOTEL EXPRESS INN, NASHIK
Dear Sir/Madam,
The Department of Pharmaceuticals along with Indian Drug
Manufacturers’ Association (IDMA) jointly presents the Fourth (4th)
Seminar in the Series of SEMINAR ON “IMPLICATIONS OF GST (GOODS
& SERVICE TAX) ON PHARMA INDUSTRY” on MONDAY, 21ST DECEMBER
2015 FROM 9:30 A.M. TO 5:00 P.M. AT HOTEL EXPRESS INN, NASHIK.
We are
pleased to be inform you that this Seminar is being organized in collaboration
with NASHIK DRUG MANUFACTURING ASSOCIATION.
Goods & Services Tax – GST – a comprehensive tax levy proposed on
manufacture, sale and consumption of goods and services at a national
level; is one of the biggest taxation reforms in India and is all set to
integrate Centre and State economics and boost overall growth. The
Cabinet on 29th July 2015 cleared the amendments suggested by Rajya
Sabha Select Committee to the Proposed GST Constitutional
Amendments Bill; the implementation of GST from 1st April 2016 is
almost a reality.
GST is an unknown economical, political, policy and administrative
challenge. Hence, many companies in corporate India specially the
Pharmaceutical Industry are concerned and unware about the real
implications of GST. Whilst uncertainty and anxiety exits in the
Pharmaceutical Industry, experts opine that GST may help in
rationalizing the tax structure and could be the single biggest shot in
the arm for the Pharmaceutical sector.
This Seminar is organized to inform and update members on the vital
implications of GST and is specially designed for:
CEOs, CFOs, Managerial Heads of Finance Divisions and Managers,
Tax Consultants and Technical Agencies, Law and Corporate
Departments
Experts will cover the following issues:
 GST- Analysis of Constitutional Amendment Bill
 Various elements of GST including its structure, proposed model,
taxes to be subsumed, tax mechanism, interstate movements of
goods and services etc.
 Draft GST Reports on Business Processes –Registration, Payment,
Return and Refund” and their critical aspects.
 Ways to integrate into GST
 Implications of GST on Pharma Industry
 Re-tuning to compliance tax systems / mechanisms
Seminar Agenda
The Agenda will be finalized shortly and sent to all.
REGISTRATION FEES : Rs.1,200/- All Inclusive
TABLE SPACES – RS.20,000/- PER TABLE
(IDMA Offers: Table Size: 6ft. x 2ft. with a power connection & Lunch for Two
delegates only)
PAYMENT DETAILS:
 By Cheque/DD should be in favour of “Indian Drug
Manufacturers’ Association”
 RTGS Details:
 BANK: CITIBANK N.A.
 ACCOUNT NAME : Indian Drug Manufacturers’ Association
 BANK Account Number : 0036274115
 IFSC Code: CITI0100000
 BRANCH: FORT BRANCH, MUMBAI – 400 001.
For further details, please contact:
 Mr. Prakash Rijhwani, GM-Costing & Management Services
Blue Cross Laboratories Pvt Ltd., A-12, M.I.D.C., Ambad, Nashik422010. Maharashtra, INDIA. Tele: 0253-2382932 Mob. 09314460125
Email : prakash.r@bluecrosslabs.com
 Mr. Chetan Patni, Managing Director
Kaytross ACG Lifesciences Ltd.
Mob. 09371810247 Email : chetan.patni@gmail.com
 Dr. Gaurav Pathak, Glenmark Pharmaceuticals Ltd.
Mob. 09405176014 Email : gaurav.pathak@glenmarkpharma.com
 Mr. Melvin Rodrigues, Sr. Manager (Commercial & Admin.)
Mobile # 9821868758 Email: actadm@idmaindia.com
Looking forward to your presence and active participation in large
numbers and working with you to make this seminar a grand success.
Thanks and regards,
Daara B. Patel
Secretary-General